IMPLICATIONS FOR PATIENTS
- IS BIODENTINE EFFECTIVE AS A PULP CAP AGENT IN CARIOUS TEETH/DIFFERENT POPULATIONS?
- BIODENTINE MECHANISM OF ACTIONS (STEM CELL PROLIFERATION CAPACITY)?
- IS BIODENTINE EFFECTIVE LONG TERM?
CONCLUSIONS BASED ON THE EVIDENCE
- BIODENTINE IS A PROMOSING AGENT
- THE GOLD STANDARD SHOULD STILL BE USED UNTIL FURTHER EVIDENCE IS RELEASED
- IN NON CARIOUS MOLARS OF HEALTHY PATIENTS, IN THE CLINICAL SCENARIO OF STERILE MECHANICAL VITAL PULP EXPOSURE, THE USE OF EITHER MTA OR BIODENTINE AS A PULP CAPPING AGENT IS BETTER THAN THE GOLD STANDARD CALCIUM HYDROXIDE BECAUSE OF THE HIGHER QUALITY OF DENTINE BRIDGE FORMATION - HOWEVER THIS WOULD ONLY BE TRUE FOR SHORT TERM APPLICATIONS, SINCE NO LONG TERM DATA IS AVAILABLE
- LOW - VERY LOW SAMPLE SIZE + UNREALISTIC CLINICAL SCENARIO, CANNOT COME TO ANY CONCLUSIONS BASED ON THE LEVEL OF EVIDENCE -> WE CAN DRAW SOME FUTURE RESEARCH RECOMMENDATIONS
WEAKNESSES OF THE STUDY
- SAMPLE SIZE TOO SMALL
- CLINICIAN CANNOT BE BLINDED
- DONE ON CARIOUS FREE TEETH, STERILE CONDITIONS
- CERTAIN EXPERIMENTAL BIASES
- OTHER OUTCOME FACTORS NOT MEASURED (IE: INFLAMMATORY CELLS)
- UNCLEAR METHODOLOGY, OMISSION OF DETAILS
- STUDY TOO SHORT, UNREALSTIC
- NO LONG TERM DATA
- DOUBLE BLIND RCT (IN THE END)
- GOOD EXPERIMENTAL DESIGN
- GENERALLY CONSISTENT
- PLOTS/GRAPHS/IMAGING USAGE - DATA ANALYSIS
- CONSISTENT USAGE OF CLINICIANS
- REASONABLE CONCLUSIONS BASED ON EVIDENCE
- POPULATION BIAS: NON HOMOGENOUS GROUPS THAT DOESNT REFLECT THE POPULATION
- SELECTION BIAS: NON RANDOMNIZED, NON CONTROL OF VARIABLES
- PERFORMANCE BIAS: OTHER VARIABLES AFFECT THE RESULTS, NON BLINDED CLINICIANS WILL TREAT CERTAIN GROUPS DIFFERENTLY (CANNOT BLIND HIM)
bias sources
RESEARCH FINDINGS
ANALYSIS
RESEARCH METHODS
RESEARCH DESIGN
- PRE-OP RADIOGRAPH TO RULE OUT PATHOLOGY/CARIES; PRE AND POST OP VITALITY TESTS
- STERILE CONDITIONS -> CLASS I PREP -> 1.5MM MECHANICAL PULP EXPOSURE
- RANDOMLY DIVIDED INTO 4 GROUPS: MTA, CA(OH)2, SBU, BIO (NO CONTROL)
- AFTER 1 WEEK -> FINAL RESTORATION PLACED (CR)
- AFTER 6 WEEKS -> XRAY/VIT TESTS -> EXTRACTION -> CBCT/HISTOLOGY (DENTINE BRIDGE ANALYSIS)
- RANDOMIZED DOUBLE BLIND CONTROLLED STUDY
- 44 3RD NON CARIOUS 3RD MOLARS SCHEDULED FOR EXTRACTIONS (21 SUBJECTS AGE 19-32)
- DURATION: 6 WEEKS
- 4 MATERIALS: CA(OH)2, MTA, BIODENTINE, SBU
- FINAL RESTORATIE MATERIAL: COMPOSITE RESIN
INCLUSION CRITERIA
- USES BOTH BIODENTINE AND MTA
- IS MEASURABLE
- RCT
- HUMAN STUDY IN VIVO
Direct Pulp Capping: Biodentine vs MTA vs Calcium hydroxide vs Single Bond Universal
ARTICLE SELECTION
databases used
Search strategy
Type of question
MATERIALS
- intervention
- Best study type: Randomized controlled trials
- Best evidence: systematic review
- BIODENTINE
- TRI-CALCIUM SILICATE: CORE
- DI-CALCIUM SILICATE: 2ND CORE
- CALCIUM CARBONATE AND OXIDE: FILLERS
- IRON OXIDE: COLOURING AGENT
- ZIRCONIUM OXIDE: RADIO OPACIFIER
- CALCIUM CHLORIDE: ACCELERATOR
- HYDROSOLUBLE POLYMER: WATER REDUCING AGENT
- MTA
- BIOCOMPATIBLE
- PORTLAND CEMENT
- DIFFICULT TO HANDLE/LONG SETTING TIME
- HIGH COST
MATERIALS
- CALCIUM HYDROXIDE
- GOLD STANDARD
- BACTERICIDAL PH=12
- POOR DENTINE BOND
- TUNEL DEFECTS
- SINGLE BOND UNIVERSAL
- NEXT GENERATION OF BOND
- TOTAL ETCH/SELF ETCH
P: young adults, non carious 3rd molars, in vivo
I: BIodentine
C: calcium hydroxide (gold standard)
O: successful direct pulp cap
Clinical question
- A sales representative presents to your office
- "we have a new material for direct pulp cap usage, it's called biodentine - it's as effective as MTA and easier to use"
Pulp Capping